{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:16:58Z","timestamp":1783703818453,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2701800, 2021YFC2701805"],"award-info":[{"award-number":["2021YFC2701800, 2021YFC2701805"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202374"],"award-info":[{"award-number":["82202374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Committee of Science and Technology","award":["22ZR1408500"],"award-info":[{"award-number":["22ZR1408500"]}]},{"name":"Shanghai Municipal Health System major supports discipline projects","award":["2023ZDFC0103"],"award-info":[{"award-number":["2023ZDFC0103"]}]},{"name":"Clinical Research Plan of Shanghai Hospital Development Center","award":["SHDC2022CRS027"],"award-info":[{"award-number":["SHDC2022CRS027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric septic shock is a critical condition associated with high mortality rates, largely due to sepsis-induced immunosuppression. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been explored as a therapeutic intervention to counteract this immunosuppression. Despite its potential, the efficacy of GM-CSF in pediatric septic shock has not been clearly established. This study aims to investigate the impact of GM-CSF administration on survival rates and to identify key predictors of treatment outcomes in pediatric septic shock patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study at the Pediatric Intensive Care Unit (PICU) of Children\u2019s Hospital of Fudan University, Shanghai, from January 1, 2019, to December 31, 2023. The study included pediatric patients diagnosed with septic shock, analyzing their demographic data, GM-CSF and adjunctive therapies, laboratory results, and clinical outcomes. We employed univariate and multivariate logistic regression models to assess the influence of GM-CSF on 28-day mortality and identify significant predictors of treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 200 pediatric patients, with 66 receiving GM-CSF treatment and 134 not treated with GM-CSF. The initial comparison showed a higher 28-day mortality in the GM-CSF group (59.1%) compared to the non-GM-CSF group (35.1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). Notably, after adjustment for confounding factors, multivariate analysis revealed that the effect of GM-CSF treatment on 28-day mortality among pediatric septic shock patients did not reach statistical significance, with an odds ratio (OR) of 0.472 and a 95% confidence interval (CI) ranging from 0.153 to 1.457 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.192). However, the analysis indicated a potential trend suggesting that GM-CSF treatment may contribute to a reduction in 28-day mortality. In addition, significant predictors of treatment outcomes included hematopoietic stem cell transplantation (HSCT), lactic acid (LAC) levels, hospital-acquired septic shock (HASS), red blood cell (RBC) count, and platelet (PLT) count.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GM-CSF treatment may benefit pediatric septic shock patients, especially those with higher lactic acid, and lower RBC and platelet counts. These factors, which are significant predictors of outcomes, should be monitored during therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-01863-6","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:11:07Z","timestamp":1738620667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients"],"prefix":"10.1186","volume":"51","author":[{"given":"Zhen-Hao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"8","key":"1863_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"10219","key":"1863_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1863_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00134-019-05878-6","volume":"46","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10\u201367.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1863_CR4","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1002\/mco2.211","volume":"4","author":"S Wang","year":"2023","unstructured":"Wang S, Yin F, Zhang Y, An K, Xi Y, Lu X et al. Epidemiology and clinical characteristics of pediatric sepsis in PICUs of China: A national cross-sectional study. MedComm (2020). 2023;4(1):e211.","journal-title":"MedComm (2020)"},{"issue":"1","key":"1863_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ccc.2017.08.007","volume":"34","author":"F Venet","year":"2018","unstructured":"Venet F, Rimmel\u00e9 T, Monneret G. Management of Sepsis-Induced Immunosuppression. Crit Care Clin. 2018;34(1):97\u2013106.","journal-title":"Crit Care Clin"},{"issue":"1","key":"1863_CR6","first-page":"56","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"key":"1863_CR7","doi-asserted-by":"publisher","first-page":"1130214","DOI":"10.3389\/fimmu.2023.1130214","volume":"14","author":"I Joshi","year":"2023","unstructured":"Joshi I, Carney WP, Rock EP. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Front Immunol. 2023;14:1130214.","journal-title":"Front Immunol"},{"key":"1863_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2022","unstructured":"Torres LK, Pickkers P, van der Poll T. Sepsis-Induced Immunosuppression. Annu Rev Physiol. 2022;84:157\u201381.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"1863_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25(1):19\u201328.","journal-title":"Nat Immunol"},{"key":"1863_CR10","doi-asserted-by":"publisher","first-page":"901277","DOI":"10.3389\/fimmu.2022.901277","volume":"13","author":"A Kumar","year":"2022","unstructured":"Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S. GM-CSF: a double-edged Sword in Cancer Immunotherapy. Front Immunol. 2022;13:901277.","journal-title":"Front Immunol"},{"key":"1863_CR11","doi-asserted-by":"publisher","first-page":"706186","DOI":"10.3389\/fimmu.2021.706186","volume":"12","author":"HM Lazarus","year":"2021","unstructured":"Lazarus HM, Ragsdale CE, Gale RP, Lyman GH. Sargramostim (rhu GM-CSF) as Cancer Therapy (systematic review) and an Immunomodulator. A drug before its time? Front Immunol. 2021;12:706186.","journal-title":"Front Immunol"},{"issue":"3","key":"1863_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37(3):525\u201332.","journal-title":"Intensive Care Med"},{"issue":"10","key":"1863_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/thoraxjnl-2017-211323","volume":"73","author":"EM Pinder","year":"2018","unstructured":"Pinder EM, Rostron AJ, Hellyer TP, Ruchaud-Sparagano MH, Scott J, Macfarlane JG, et al. Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. Thorax. 2018;73(10):918\u201325.","journal-title":"Thorax"},{"issue":"7","key":"1863_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180(7):640\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1863_CR15","doi-asserted-by":"publisher","first-page":"154330","DOI":"10.1016\/j.jcrc.2023.154330","volume":"78","author":"CH Vacheron","year":"2023","unstructured":"Vacheron CH, Lepape A, Venet F, Monneret G, Gueyffier F, Boutitie F, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: the GRID randomized controlled trial. J Crit Care. 2023;78:154330.","journal-title":"J Crit Care"},{"issue":"11","key":"1863_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12519-022-00574-w","volume":"18","author":"GY Su","year":"2022","unstructured":"Su GY, Fan CN, Fang BL, Xie ZD, Qian SY. Comparison between hospital- and community-acquired septic shock in children: a single-center retrospective cohort study. World J Pediatr. 2022;18(11):734\u201345.","journal-title":"World J Pediatr"},{"issue":"1","key":"1863_CR17","first-page":"51","volume":"30","author":"L Zhang","year":"2018","unstructured":"Zhang L, Huang H, Cheng Y, Xu L, Huang X, Pei Y, et al. [Predictive value of four pediatric scores of critical illness and mortality on evaluating mortality risk in pediatric critical patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(1):51\u20136.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"1863_CR18","unstructured":"Becher B, Tugues S, Greter M. GM-CSF: from growth factor to Central Mediator of tissue inflammation. (1097\u20134180 (Electronic))."},{"issue":"50","key":"1863_CR19","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1097\/MD.0000000000002044","volume":"94","author":"B Mathias","year":"2015","unstructured":"Mathias B, Szpila BE, Moore FA, Efron PA, Moldawer LL. A review of GM-CSF Therapy in Sepsis. Med (Baltim). 2015;94(50):e2044.","journal-title":"Med (Baltim)"},{"issue":"4","key":"1863_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","volume":"195","author":"HM Mehta","year":"2015","unstructured":"Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in Neutropenia. J Immunol. 2015;195(4):1341\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"1863_CR21","first-page":"468","volume":"88","author":"S Cetean","year":"2015","unstructured":"Cetean S, C\u0103inap C, Constantin AM, C\u0103inap S, Gherman A, Oprean L, et al. The importance of the granulocyte-colony stimulating factor in oncology. Clujul Med. 2015;88(4):468\u201372.","journal-title":"Clujul Med"},{"issue":"4","key":"1863_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood.2019000952","volume":"136","author":"GR Hill","year":"2020","unstructured":"Hill GR, Koyama M. Cytokines and costimulation in acute graft-versus-host disease. Blood. 2020;136(4):418\u201328.","journal-title":"Blood"},{"issue":"2","key":"1863_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/SHK.0000000000000958","volume":"49","author":"B Nolt","year":"2018","unstructured":"Nolt B, Tu F, Wang X, Ha T, Winter R, Williams DL, et al. Lactate and Immunosuppression in Sepsis. Shock. 2018;49(2):120\u20135.","journal-title":"Shock"},{"issue":"17","key":"1863_CR24","doi-asserted-by":"publisher","first-page":"eabm8965","DOI":"10.1126\/sciadv.abm8965","volume":"8","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Gill PS, et al. Lactate induces vascular permeability via disruption of VE-cadherin in endothelial cells during sepsis. Sci Adv. 2022;8(17):eabm8965.","journal-title":"Sci Adv"},{"issue":"6","key":"1863_CR25","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1097\/CCM.0000000000003030","volume":"46","author":"SM Ryoo","year":"2018","unstructured":"Ryoo SM, Lee J, Lee YS, Lee JH, Lim KS, Huh JW, et al. Lactate Level Versus Lactate Clearance for Predicting Mortality in patients with septic shock defined by Sepsis-3. Crit Care Med. 2018;46(6):e489\u201395.","journal-title":"Crit Care Med"},{"key":"1863_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2015.05.024","volume":"37","author":"G Dabar","year":"2015","unstructured":"Dabar G, Harmouche C, Salameh P, Jaber BL, Jamaleddine G, Waked M, et al. Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study. Int J Infect Dis. 2015;37:80\u20135.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1863_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13049-019-0596-4","volume":"27","author":"H Minasyan","year":"2019","unstructured":"Minasyan H. Sepsis: mechanisms of bacterial injury to the patient. Scand J Trauma Resusc Emerg Med. 2019;27(1):19.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"616","key":"1863_CR28","doi-asserted-by":"publisher","first-page":"eabj1008","DOI":"10.1126\/scitranslmed.abj1008","volume":"13","author":"LKM Lam","year":"2021","unstructured":"Lam LKM, Murphy S, Kokkinaki D, Venosa A, Sherrill-Mix S, Casu C, et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia. Sci Transl Med. 2021;13(616):eabj1008.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1863_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10753-018-0810-y","volume":"41","author":"K Effenberger-Neidnicht","year":"2018","unstructured":"Effenberger-Neidnicht K, Hartmann M. Mechanisms of Hemolysis during Sepsis. Inflammation. 2018;41(5):1569\u201381.","journal-title":"Inflammation"},{"key":"1863_CR30","doi-asserted-by":"crossref","unstructured":"Agnello L, Giglio RV, Bivona G, Scazzone C, Gambino CM, Iacona A et al. The value of a complete blood Count (CBC) for Sepsis diagnosis and prognosis. Diagnostics (Basel). 2021;11(10).","DOI":"10.3390\/diagnostics11101881"},{"key":"1863_CR31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fimmu.2019.01687","volume":"10","author":"A Assinger","year":"2019","unstructured":"Assinger A, Schrottmaier WC, Salzmann M, Rayes J. Platelets in Sepsis: an update on experimental models and Clinical Data. Front Immunol. 2019;10:1687.","journal-title":"Front Immunol"},{"issue":"7","key":"1863_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MBC.0000000000000937","volume":"31","author":"GA Harbi","year":"2020","unstructured":"Harbi GA, Chaari A. Platelets parameters in septic shock: clinical usefulness and prognostic value. Blood Coagul Fibrinolysis. 2020;31(7):421\u20135.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1863_CR33","doi-asserted-by":"publisher","first-page":"1210219","DOI":"10.3389\/fimmu.2023.1210219","volume":"14","author":"D Cox","year":"2023","unstructured":"Cox D. Sepsis - it is all about the platelets. Front Immunol. 2023;14:1210219.","journal-title":"Front Immunol"},{"key":"1863_CR34","doi-asserted-by":"crossref","unstructured":"Unar A, Bertolino L, Patauner F, Gallo R, Durante-Mangoni E. Pathophysiology of disseminated intravascular coagulation in Sepsis: a clinically focused overview. Cells. 2023;12(17).","DOI":"10.3390\/cells12172120"},{"issue":"24","key":"1863_CR35","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","volume":"127","author":"TA Claushuis","year":"2016","unstructured":"Claushuis TA, van Vught LA, Scicluna BP, Wiewel MA, Klein Klouwenberg PM, Hoogendijk AJ, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. 2016;127(24):3062\u201372.","journal-title":"Blood"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01863-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:11:22Z","timestamp":1738620682000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01863-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01863-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4790762\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Medical Ethics Committee of the Children\u2019s Hospital of Fudan University [No.97 (2024)] and was conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The patient\u2019s informed consent has been obtained from the patient\u2019s legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from legal guardians of all patients who participated in the study for publication of anonymous patients\u2019 data","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"25"}}